West Pharmaceutical Services Earnings
NYSE: WSTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 22, 2026
Fiscal period
Sep/2026
EPS estimate
$2.18
West Pharmaceutical Services earnings summary
West Pharmaceutical Services is scheduled to report Sep/2026 earnings on Oct 22, 2026, with analysts expecting EPS of $2.18. In its most recent report on Jul 23, 2026 (Q2 2026), WST posted EPS of $2.15. Revenue for the quarter was $872.3 million.
Quarterly EPS is up 18.1% from the same quarter a year earlier. Across the last 16 reports, WST shares moved an average of 4.3% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
WST earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 23, 2026 | — | $2.15 | — | +3.9% |
| Apr 23, 2026 | — | $1.92 | — | -1.8% |
| Feb 17, 2026 | — | $1.82 | — | +5.5% |
| Oct 23, 2025 | — | $1.92 | — | -5.2% |
| Jul 24, 2025 | — | $1.82 | — | -9.2% |
| Apr 24, 2025 | — | $1.23 | — | -1.5% |
| Feb 18, 2025 | — | $1.78 | — | +10.2% |
| Oct 24, 2024 | — | $1.85 | — | +2.8% |
| Jul 25, 2024 | — | $1.51 | — | +5.5% |
| Apr 25, 2024 | — | $1.55 | — | +1.3% |
| Feb 20, 2024 | — | $1.83 | — | -2.4% |
| Oct 26, 2023 | — | $2.14 | — | +4.4% |
| Jul 27, 2023 | — | $2.06 | — | +2.6% |
| Apr 27, 2023 | — | $1.85 | — | +2.0% |
| Feb 21, 2023 | — | $1.37 | — | +6.1% |
| Oct 27, 2022 | — | $1.59 | — | -4.4% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.